Epoxomicin (BU-4061T)

别名: Aids010837 中文名称:环氧酶素

Epoxomicin (BU-4061T, Aids010837) 是一种选择性蛋白酶体抑制剂,具有抗炎活性,首要抑制20S蛋白酶体的CH-L活性,也抑制T-L和PGPH催化活性。Epoxomicin 可促进凋亡。

Epoxomicin (BU-4061T) Chemical Structure

Epoxomicin (BU-4061T) Chemical Structure

CAS: 134381-21-8

规格 价格 库存 购买数量
10mM (1mL in DMSO) 5561.01 现货
1mg 1531.53 现货
5mg 4725.63 现货
25mg 14496.3 现货
100mg 29900 现货
更大包装 有超大折扣

400-668-6834

info@selleck.cn

免费分装
免费预溶

产品质控

批次: S703801 DMSO]100 mg/mL]false]Ethanol]100 mg/mL]false]Water]Insoluble]false 纯度: 99.87%
99.87

Epoxomicin (BU-4061T)相关产品

相关信号通路图

细胞实验数据示例

细胞系 实验类型 给药浓度 孵育时间 活性描述 文献信息
DLD1 Function assay 6 hrs Inhibition of chymotrypsin-like activity of 20S proteasome in human DLD1 cells transfected with 4Ub-Luc gene using Succinyl-Leu-Leu-Val-Tyr-AMC as substrate after 6 hrs by spectrofluorometric analysis, IC50 = 0.006 μM. 22206869
LCL Function assay 12 hrs Inhibition of chymotrypsin-like activity of 20S proteasome beta2 in human LCL cells after 12 hrs, IC50 = 0.005 μM. 20687609
WM266.4 Cytotoxicity assay 72 hrs Cytotoxicity against human WM266.4 cells after 72 hrs by ATPlite assay, IC50 = 0.0048 μM. 22206869
HEK293 Function assay 2 hrs Inhibition of chymotrypsin-like activity of proteasome beta-5 subunit in HEK293 cells using Suc-LLVY-Glo as substrate incubated for 2 hrs prior to substrate addition measured after 10 mins by cell-based proteasome-Glo beta5 assay, IC50 = 0.026 μM. 23540790
DLD1 Function assay 6 hrs Inhibition of peptide-glutamyl-peptide-hydrolyzing activity of 20S proteasome in human DLD1 cells transfected with 4Ub-Luc gene using Z-Leu-Leu-Glu-AMC as substrate after 6 hrs by spectrofluorometric analysis, IC50 = 0.06 μM. 22206869
LCL Function assay 12 hrs Inhibition of trypsin-like activity of 20S proteasome beta2 in human LCL cells after 12 hrs, IC50 = 0.284 μM. 20687609
HEK293 Function assay 2 hrs Inhibition of postacid activity of 20s proteasome beta-1 subunit in HEK293 cells using Z-nLPnLD-Glo as substrate incubated for 2 hrs prior to substrate addition measured after 10 mins by cell-based proteasome-Glo beta1 assay, IC50 = 0.3 μM. 23540790
LCL Function assay 12 hrs Inhibition of PGPH catalytic activity of 20S proteasome beta2 in human LCL cells after 12 hrs, IC50 = 4.56 μM. 20687609
lymphoblastoid cells Function assay Inhibition of chymotrypsin like 20S proteasome activity in lymphoblastoid cells, IC50 = 0.005 μM. 17996987
PC3 Antiproliferative assay Antiproliferative activity against human PC3 cell line, IC50 = 0.001 μM. 16686537
lymphoblastoid cells Function assay Inhibition of trypsin like 20S proteasome activity in lymphoblastoid cells, IC50 = 0.284 μM. 17996987
KB-8-5-11 Function assay P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen, Potency = 2.5929 μM. 31515284
lymphoblastoid cells Function assay Inhibition of caspase like 20S proteasome activity in lymphoblastoid cells, IC50 = 4.56 μM. 17996987
KB-3-1 Function assay P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen 31515284
点击查看更多细胞系数据

生物活性

产品描述 Epoxomicin (BU-4061T, Aids010837) 是一种选择性蛋白酶体抑制剂,具有抗炎活性,首要抑制20S蛋白酶体的CH-L活性,也抑制T-L和PGPH催化活性。Epoxomicin 可促进凋亡。
特性 Epoxomicin是从Actinomycetes物种中分离的天然产物。
靶点
20S proteasome [1]
体外研究(In Vitro)
体外研究活性

Epoxomicin共价结合到LMP7, X, MECL1,和蛋白酶体的Z催化亚基。Epoxomicin (100 nM)处理HUVECs,使p53蛋白水平增加30倍。Epoxomicin (10 μM)作用于HeLa细胞,导致泛素化蛋白累积。Epoxomicin(10 μM)作用于HeLa细胞,抑制IκBα降解。Epoxomicin(10 μM)作用于HeLa细胞,显著降低TNF-α刺激的NF-κB DNA结合活性,这种作用存在剂量依赖性。[1]

Epoxomicin抑制EL4 淋巴瘤细胞增殖,IC50为4 nM。[2]

Epoxomicin(1 μM) 降低LCMV GP33和增强 GP276。[3]

Epoxomicin 抑制Babesia bigemina生长,IC50为4 nM。Epoxomicin按0.5 mg/kg和0.05 mg/kg剂量处理B. microti,虫血症峰值分别为34.8% 和42.3%。[4]

Epoxomicin (100 nM)处理Plasmodium falciparum,降低78%, 86% 和77%虫血症。Epoxomicin (10 μM) 抑制配子和小配子形成按蚊的卵囊。[5]

体内研究(In Vivo)
体内研究活性

Epoxomicin 每天按0.58 mg/kg剂量处理,与空白对照组小鼠相比,降低44% CS反应。Epoxomicin (2.9 mg/kg)处理小鼠,24小时后,测量耳肿胀,有效地抑制95%刺激性相关的炎症反应。[1]

动物实验 Animal Models BALB/c小鼠
Dosages 2.9 mg/kg
Administration 腹腔注射

化学信息&溶解度

分子量 554.72 分子式

C28H50N4O7

CAS号 134381-21-8 SDF Download Epoxomicin (BU-4061T) SDF
Smiles CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(C)C)C(=O)C1(CO1)C)NC(=O)C(C(C)CC)N(C)C(=O)C
储存条件(自收到货起)

体外溶解度
批次:

DMSO : 100 mg/mL ( (180.27 mM) ;DMSO吸湿会降低化合物溶解度,请使用新开封DMSO)

Ethanol : 100 mg/mL (180.27 mM)

Water : Insoluble

摩尔浓度计算器

体内溶解度
批次:

现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂

动物体内配方计算器

实验计算

摩尔浓度计算器

质量 浓度 体积 分子量

动物体内配方计算器(澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)

mg/kg g μL

第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)

% DMSO % % Tween 80 % ddH2O
%DMSO %

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于μL DMSO溶液(母液浓度mg/mL,:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);

体内配方配制方法:μL DMSO母液,加入μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入μL ddH2O,混匀澄清。

体内配方配制方法:μL DMSO母液,加入μL Corn oil,混匀澄清。

注意:1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

* 必填项

请输入您的姓名
请输入您的邮箱地址 请输入一个有效的邮箱地址
请写点东西给我们
Tags: buy Epoxomicin (BU-4061T) | Epoxomicin (BU-4061T) supplier | purchase Epoxomicin (BU-4061T) | Epoxomicin (BU-4061T) cost | Epoxomicin (BU-4061T) manufacturer | order Epoxomicin (BU-4061T) | Epoxomicin (BU-4061T) distributor
在线咨询
联系我们